Doximity earnings release, August 6, 2026

Doximity, Inc. (DOCS) · Form 8-K, Item 2.02 · Filed · SEC filing

Doximity Announces Fiscal 2027 First Quarter Financial Results

Total revenues of $156.6 million, up 7% year-over-year

Net income of $24.3 million, margin of 16%

Adjusted EBITDA of $74.8 million, margin of 48%

SAN FRANCISCO, Calif., August 6, 2026

-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026.

“We're proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we delivered another quarter of record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. "In Q1 we had accelerated revenue growth along with workflow active prescriber growth of more than 30% year-over-year and AI Search query growth of over 25% quarter-over-quarter.”

Fiscal 2027 First Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended June 30, 2025.

• Revenue:

Revenue of $156.6 million, versus $145.9 million, an increase of 7% year-over-year.

• Net income and non-GAAP net income:

Net income of $24.3 million, versus $53.3 million, representing a margin of 15.5%, versus 36.5%. Non-GAAP net income of $55.0 million, versus $71.9 million, representing a margin of 35.1%, versus 49.2%.

• Adjusted EBITDA:

Adjusted EBITDA of $74.8 million, versus $79.8 million, a decrease of 6% year-over-year, representing adjusted EBITDA margins of 47.7%, versus 54.7%.

• Diluted net income per share and non-GAAP diluted net income per share:

Diluted net income per share was $0.13, versus $0.27, while non-GAAP diluted net income per share was $0.29, versus $0.36.

• Operating cash flow and free cash flow

: Operating cash flow of $42.0 million, versus $62.1 million, a decrease of 32% year-over-year, and free cash flow of $39.6 million, versus $60.1 million, a decrease of 34% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal second quarter ending September 30, 2026 as follows:

• Revenue between $170 million and $171 million.

• Adjusted EBITDA between $80.5 million and $81.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:

• Revenue between $671 million and $681 million.

• Adjusted EBITDA between $309 million and $329 million.

For more detailed financial commentary, please refer to the “Modeling Considerations” appendix in our prepared remarks.¹

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The recorded webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Financial statements

Income Statement

Three Months Ended June 30, — (unaudited)

Three Months Ended June 30, – 20262025
Revenue156,618145,913
Cost of revenue(1)23,69215,793
Gross profit132,926130,120
Operating expenses(1):Research and development38,47726,799
Operating expenses(1):Sales and marketing45,04936,365
Operating expenses(1):General and administrative15,75612,439
Operating expenses(1):Total operating expenses99,28275,603
Operating expenses(1):Income from operations33,64454,517
Operating expenses(1):Other income, net6,7199,630
Operating expenses(1):Income before income taxes40,36364,147
Operating expenses(1):Provision for income taxes16,04810,827
Operating expenses(1):Net income24,31553,320
Net income per share attributable to Class A and Class B common stockholders:Basic0.130.28
Net income per share attributable to Class A and Class B common stockholders:Diluted0.130.27
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Basic182,569187,984
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:Diluted191,169201,158

Income Statement

Three Months Ended June 30, — (1) Costs and expenses include stock-based compensation expense as follows (in thousands):

Three Months Ended June 30, – 20262025
Cost of revenue3,1922,980
Research and development15,5596,649
Sales and marketing12,4257,710
General and administrative5,5764,526
Total stock-based compensation expense36,75221,865

Income Statement

Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended June 30, – 2026 – (unaudited)2025 – (unaudited)
Net income24,31553,320
Adjusted to exclude the following:Acquisition and other related expenses428
Adjusted to exclude the following:Stock-based compensation36,75221,865
Adjusted to exclude the following:Depreciation and amortization4,2872,794
Adjusted to exclude the following:Provision for income taxes16,04810,827
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability90168
Adjusted to exclude the following:Other income, net-6,719-9,630
Adjusted to exclude the following:Adjusted EBITDA74,77379,772
Adjusted to exclude the following:Revenue156,618145,913
Adjusted to exclude the following:Net income margin15.536.5
Adjusted to exclude the following:Adjusted EBITDA margin47.754.7

Income Statement

Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended June 30, – 2026 – (unaudited)2025 – (unaudited)
GAAP cost of revenue23,69215,793
Adjusted to exclude the following:Stock-based compensation-3,192-2,980
Adjusted to exclude the following:Amortization of acquired intangibles-935
Adjusted to exclude the following:Non-GAAP cost of revenue19,56512,813
Adjusted to exclude the following:GAAP gross profit132,926130,120
Adjusted to exclude the following:Stock-based compensation3,1922,980
Adjusted to exclude the following:Amortization of acquired intangibles935
Adjusted to exclude the following:Non-GAAP gross profit137,053133,100
Adjusted to exclude the following:GAAP gross margin84.989.2%
Adjusted to exclude the following:Non-GAAP gross margin87.591.2%
Adjusted to exclude the following:GAAP research and development expense38,47726,799
Adjusted to exclude the following:Stock-based compensation-15,559-6,649
Adjusted to exclude the following:Non-GAAP research and development expense22,91820,150
Adjusted to exclude the following:GAAP sales and marketing expense45,04936,365
Adjusted to exclude the following:Stock-based compensation-12,425-7,710
Adjusted to exclude the following:Amortization of acquired intangibles-1,005-1,002
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability-90-168
Adjusted to exclude the following:Non-GAAP sales and marketing expense31,52927,485
Adjusted to exclude the following:GAAP general and administrative expense15,75612,439
Adjusted to exclude the following:Acquisition and other related expenses-428
Adjusted to exclude the following:Stock-based compensation-5,576-4,526
Adjusted to exclude the following:Non-GAAP general and administrative expense10,1807,485
Adjusted to exclude the following:GAAP operating expense99,28275,603
Adjusted to exclude the following:Acquisition and other related expenses-428
Adjusted to exclude the following:Stock-based compensation-33,560-18,885
Adjusted to exclude the following:Amortization of acquired intangibles-1,005-1,002
Adjusted to exclude the following:Change in fair value of contingent earn-out consideration liability-90-168
Adjusted to exclude the following:Non-GAAP operating expense64,62755,120

Income Statement

Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended June 30, – 2026 – (unaudited)2025 – (unaudited)
GAAP operating income33,64454,517
Adjusted to exclude the following:Acquisition and other related expenses428
Adjusted to exclude the following:Stock-based compensation36,75221,865

Balance Sheet

June 30, 2026 — (unaudited)

June 30, 2026March 31, 2026
Current assets:Cash and cash equivalents273,604219,178
Current assets:Marketable securities414,185529,423
Current assets:Accounts receivable, net177,575144,783
Current assets:Prepaid expenses and other current assets48,61450,880
Current assets:Total current assets913,978944,264
Current assets:Property and equipment, net19,24318,080
Current assets:Deferred income tax assets23,83931,984
Current assets:Operating lease right-of-use assets6,7527,140
Current assets:Intangible assets, net33,38535,325
Current assets:Goodwill84,97384,973
Current assets:Other assets1,6751,921
Current assets:Total assets1,083,8451,123,687
Current liabilities:Accounts payable6,4944,009
Current liabilities:Accrued expenses and other current liabilities32,66642,804
Current liabilities:Deferred revenue, current109,061106,050
Current liabilities:Operating lease liabilities, current2,1422,110
Current liabilities:Total current liabilities150,363154,973
Current liabilities:Deferred revenue, non-current37400
Current liabilities:Operating lease liabilities, non-current7,5318,075
Current liabilities:Other liabilities, non-current9,8449,402
Current liabilities:Total liabilities167,775172,850
Stockholders' EquityCommon stock180183
Stockholders' EquityAdditional paid-in capital1,035,2821,001,688
Stockholders' EquityAccumulated other comprehensive income (loss)-34828
Stockholders' EquityAccumulated deficit-119,044-51,062
Stockholders' EquityTotal stockholders’ equity916,070950,837
Stockholders' EquityTotal liabilities and stockholders’ equity1,083,8451,123,687

Cash Flow

Three Months Ended June 30, — (unaudited)

Three Months Ended June 30, – 20262025
Cash flows from operating activitiesNet income24,31553,320
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization4,2872,794
Adjustments to reconcile net income to net cash provided by operating activities:Stock-based compensation, net of amounts capitalized36,75221,865
Adjustments to reconcile net income to net cash provided by operating activities:Non-cash lease expense387450
Adjustments to reconcile net income to net cash provided by operating activities:Accretion of discount on marketable securities, net-568-2,488
Adjustments to reconcile net income to net cash provided by operating activities:Amortization of deferred contract costs4,3003,896
Adjustments to reconcile net income to net cash provided by operating activities:Other-338-408
Changes in operating assets and liabilities:Accounts receivable-33,334-13,381
Changes in operating assets and liabilities:Prepaid expenses and other assets9,125-4,234
Changes in operating assets and liabilities:Deferred contract costs-2,642-1,965
Changes in operating assets and liabilities:Accounts payable, accrued expenses and other liabilities-2,433-165
Changes in operating assets and liabilities:Deferred revenue2,6482,973
Changes in operating assets and liabilities:Operating lease liabilities-512-556
Changes in operating assets and liabilities:Net cash provided by operating activities41,98762,101
Cash flows from investing activitiesPurchases of property and equipment-62
Cash flows from investing activitiesInternal-use software development costs-2,322-1,966
Cash flows from investing activitiesPurchases of marketable securities-14,746-139,934
Cash flows from investing activitiesMaturities of marketable securities126,071144,579
Cash flows from investing activitiesSales of marketable securities4,049
Cash flows from investing activitiesNet cash provided by investing activities112,9902,679
Cash flows from financing activitiesProceeds from issuance of common stock upon exercise of stock options and common stock warrants3,0802,398
Cash flows from financing activitiesTaxes paid related to net share settlement of equity awards-6,974-11,927
Cash flows from financing activitiesRepurchase of common stock-91,633-122,355

Cash Flow

Three Months Ended June 30, — The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below: (in thousands)

Three Months Ended June 30, – 2026 – (unaudited)2025 – (unaudited)
Net cash provided by operating activities41,98762,101
Purchases of property and equipment-62
Internal-use software development costs-2,322-1,966
Free cash flow39,60360,135
Other cash flow components:Net cash provided by investing activities112,9902,679
Other cash flow components:Net cash used in financing activities-100,551-137,133
Full release

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements are all statements other than statements of historical fact, and specifically include statements regarding guidance and future business and financial results. These statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Perry Gold ir@doximity.com

Media Contact:

Richard George pr@doximity.com²

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.